Publication | Closed Access
Five Month Survival in a Calf Supported With an Intraventricular Axial Flow Blood Pump
10
Citations
0
References
1995
Year
Heart FailureSurgeryBiomedical EngineeringBlood FlowArtificial OrganThrombosisVascular SurgeryPermanent ImplantationCardiologyBlood Flow MeasurementAssisted CirculationVascular BiologyBiomedical FlowJarvik 2000Cardiovascular DiseasePhysiologyMonth SurvivalMechanical Circulatory SupportContinuous Flow PumpCalf SupportedMedicineAnesthesiology
We are studying in vivo an intraventricular axial flow blood pump (Jarvik 2000) designed for long-term left ventricular support. The small (25 cc, 85 g) valveless pump has been placed intraventricularly in seven calves; pumps have functioned for as long as 5 months. In the four most recent long-term studies completed, calves have survived for 70, 120, 155, and 162 days (in that order); weight gain has averaged 0.56 kg/day. One study is ongoing at more than 30 days. Under resting physiologic conditions in the normal calf, the continuous flow pump produces flows of 5-6 L/min with a decreased arterial pulse contour. The device has caused no physiologic complications. Calves in the completed studies had mean free plasma hemoglobin levels of 11.4, 7.1, 6.5, and 4.3 mg/dl, respectively. We have modified the inflow structures of the device, and these results suggest that a thrombus free design with no pannus at or around the inlet of the pump can be achieved. Histopathologic analyses of the heart and kidneys in studies of as long as 5 months show no deleterious effects of this device. These studies demonstrate the feasibility of a small implanted intraventricular blood pump for long-term use. Future developments for permanent implantation will include implanted physiologic control systems, transcutaneous energy transmission systems, and implanted batteries.